Tydings C, Singh B, Smith A, Ledwitch K, Brown B, Lovly C
Protein Sci. 2024; 33(10):e5141.
PMID: 39275996
PMC: 11400634.
DOI: 10.1002/pro.5141.
Chen Y, Xiong T, Peng Q, Du J, Sun W, Fan J
Nat Commun. 2024; 15(1):6935.
PMID: 39138197
PMC: 11322375.
DOI: 10.1038/s41467-024-51253-5.
Dinesen A, Andersen V, Elkhashab M, Pilati D, Bech P, Fuchs E
Bioconjug Chem. 2024; 35(2):214-222.
PMID: 38231391
PMC: 10886128.
DOI: 10.1021/acs.bioconjchem.3c00491.
Comez D, Glenn J, Anbuhl S, Heukers R, Smit M, Hill S
Front Immunol. 2022; 13:1006718.
PMID: 36505413
PMC: 9726709.
DOI: 10.3389/fimmu.2022.1006718.
Yan Q, Cai M, Zhou L, Xu H, Shi Y, Sun J
Nanoscale Adv. 2022; 1(1):291-298.
PMID: 36132464
PMC: 9473275.
DOI: 10.1039/c8na00143j.
Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies.
Stam J, de Maat S, De Jong D, Arens M, van Lint F, Gharu L
Sci Rep. 2022; 12(1):13413.
PMID: 35927444
PMC: 9352707.
DOI: 10.1038/s41598-022-15993-y.
A Nanobody-on-Quantum Dot Displacement Assay for Rapid and Sensitive Quantification of the Epidermal Growth Factor Receptor (EGFR).
Su R, Wu Y, Doulkeridou S, Qiu X, Sorensen T, Susumu K
Angew Chem Int Ed Engl. 2022; 61(33):e202207797.
PMID: 35759268
PMC: 9542526.
DOI: 10.1002/anie.202207797.
Conjugation of IRDye Photosensitizers or Fluorophores to Nanobodies.
Mashayekhi V, Oliveira S
Methods Mol Biol. 2022; 2451:495-503.
PMID: 35505027
DOI: 10.1007/978-1-0716-2099-1_22.
Structural insights into the non-inhibitory mechanism of the anti-EGFR EgB4 nanobody.
Zeronian M, Doulkeridou S, Van Bergen en Henegouwen P, Janssen B
BMC Mol Cell Biol. 2022; 23(1):12.
PMID: 35232398
PMC: 8887186.
DOI: 10.1186/s12860-022-00412-x.
Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer.
Tapia-Galisteo A, Sanchez Rodriguez I, Aguilar-Sopena O, Harwood S, Narbona J, Ferreras Gutierrez M
Oncoimmunology. 2022; 11(1):2034355.
PMID: 35154908
PMC: 8837253.
DOI: 10.1080/2162402X.2022.2034355.
Case Report: An EGFR-Targeted 4-1BB-agonistic Trimerbody Does Not Induce Hepatotoxicity in Transgenic Mice With Liver Expression of Human EGFR.
Compte M, Harwood S, Martinez-Torrecuadrada J, Perez-Chacon G, Gonzalez-Garcia P, Tapia-Galisteo A
Front Immunol. 2021; 11:614363.
PMID: 33488625
PMC: 7817978.
DOI: 10.3389/fimmu.2020.614363.
Nanobodies in cancer.
Verhaar E, Woodham A, Ploegh H
Semin Immunol. 2020; 52:101425.
PMID: 33272897
PMC: 8164649.
DOI: 10.1016/j.smim.2020.101425.
Auxin-induced signaling protein nanoclustering contributes to cell polarity formation.
Pan X, Fang L, Liu J, Senay-Aras B, Lin W, Zheng S
Nat Commun. 2020; 11(1):3914.
PMID: 32764676
PMC: 7410848.
DOI: 10.1038/s41467-020-17602-w.
Elevating EGFR-MAPK program by a nonconventional Cdc42 enhances intestinal epithelial survival and regeneration.
Zhang X, Bandyopadhyay S, Araujo L, Tong K, Flores J, Laubitz D
JCI Insight. 2020; 5(16).
PMID: 32686657
PMC: 7455142.
DOI: 10.1172/jci.insight.135923.
Recent Advances of Magnetic Nanomaterials in the Field of Oncology.
Li T, Yang C, Wei Z, Pei D, Jiang G
Onco Targets Ther. 2020; 13:4825-4832.
PMID: 32547109
PMC: 7266512.
DOI: 10.2147/OTT.S243256.
EGFR-Targeted Nanobody Functionalized Polymeric Micelles Loaded with mTHPC for Selective Photodynamic Therapy.
Liu Y, Scrivano L, Peterson J, Fens M, Hernandez I, Mesquita B
Mol Pharm. 2020; 17(4):1276-1292.
PMID: 32142290
PMC: 7140040.
DOI: 10.1021/acs.molpharmaceut.9b01280.
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock.
Dong Z, Zhang G, Qu M, Gimple R, Wu Q, Qiu Z
Cancer Discov. 2019; 9(11):1556-1573.
PMID: 31455674
PMC: 6983300.
DOI: 10.1158/2159-8290.CD-19-0215.
Plasma Membrane-Associated Receptor-like Kinases Relocalize to Plasmodesmata in Response to Osmotic Stress.
Grison M, Kirk P, Brault M, Wu X, Schulze W, Benitez-Alfonso Y
Plant Physiol. 2019; 181(1):142-160.
PMID: 31300470
PMC: 6716232.
DOI: 10.1104/pp.19.00473.
Active Targeting of Cancer Cells by Nanobody Decorated Polypeptide Micelle with Bio-orthogonally Conjugated Drug.
Costa S, Mozhdehi D, Dzuricky M, Isaacs F, Brustad E, Chilkoti A
Nano Lett. 2018; 19(1):247-254.
PMID: 30540482
PMC: 6465085.
DOI: 10.1021/acs.nanolett.8b03837.
The architecture of EGFR's basal complexes reveals autoinhibition mechanisms in dimers and oligomers.
Zanetti-Domingues L, Korovesis D, Needham S, Tynan C, Sagawa S, Roberts S
Nat Commun. 2018; 9(1):4325.
PMID: 30337523
PMC: 6193980.
DOI: 10.1038/s41467-018-06632-0.